GGrantIndex
Sort

15,440 grants matching organoids

Role of fibroblastic stromal cells and notch signaling in tissue inflammation in RA and SLE

$498,352
Michael B Brenner · Brigham And Women'S Hospital · P01 · FY2022 · AI

High-Throughput Volumetric Photoacoustic Imaging of Living Vascularized Organoids

$498,268
Junjie Yao · Duke University · R01 · FY2020 · EB

Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers

$498,202
John D Gordan · University Of California, San Francisco · R37 · FY2024 · CA

Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice

$498,165
Kathleen R. Cho · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice

$498,165
Kathleen R. Cho · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

The role of ectodermal-neural cortex 1 in selective neuronal vulnerability in aging and Alzheimer's disease

$498,043
Hongjun Fu · Ohio State University · R56 · FY2020 · AG

The Transport of Nutritional Heme in Animal Development

$497,976
Iqbal Hamza · Univ Of Maryland, College Park · R01 · FY2016 · DK

The role of TRIM37 in driving tumorigenesis and cancer-specific vulnerability to PLK4 inhibition

$497,839
Sergi Regot · Johns Hopkins University · R01 · FY2023 · CA

Project-1: Comprehensive phenotypic and genetic assessment of TE birth defects in patients

$497,750
Wendy K Chung · Cincinnati Childrens Hosp Med Ctr · P01 · FY2022 · HD

Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage.

$497,731
Radhakrishna Rao · University Of Tennessee Health Sci Ctr · R01 · FY2025 · AA

Mitigation of GI-ARS by Lactobacillus species

$497,663
Radhakrishna Rao · University Of Tennessee Health Sci Ctr · U01 · FY2024 · AI

Pharmacological and dietary inhibition of a novel metabolic-epigenetic crosstalk in head and neck cancer

$497,650
De-Chen Lin · University Of Southern California · R01 · FY2025 · DE

In Vivo Prevention of Murine GVHD

$497,610
Bruce R. Blazar · University Of Minnesota · R37 · FY2017 · AI

Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer

$497,575
Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2025 · CA

Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer

$497,573
Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2023 · CA

Molecular mechanisms and therapeutic targeting of PI3K-p110beta/PTEN signaling in breast cancer and cancer immunity

$497,522
Thomas M Roberts · Dana-Farber Cancer Inst · R01 · FY2019 · CA

High-Throughput Volumetric Photoacoustic Imaging of Living Vascularized Organoids

$497,469
Junjie Yao · Duke University · R01 · FY2022 · EB

A novel strategy to overcome drug resistance in cancer

$497,379
Aimee L Edinger · University Of California-Irvine · R01 · FY2021 · CA

Leader cell development and function in Breast Tumor Collective Migration

$497,352
Gregory Longmore · Washington University · R01 · FY2023 · CA

Molecular control of a novel transitional cell state in alveolar regeneration

$497,340
Purushothama Rao Tata · Duke University · R01 · FY2022 · HL

Molecular control of a novel transitional cell state in alveolar regeneration

$497,340
Purushothama Rao Tata · Duke University · R01 · FY2023 · HL

Pharmacological and dietary inhibition of a novel metabolic-epigenetic crosstalk in head and neck cancer

$497,275
De-Chen Lin · University Of Southern California · R01 · FY2024 · DE

Novel Roles of Placental Allopregnanolone in Brain Development and Injury

$497,208
Anna A Penn · Columbia University Health Sciences · R01 · FY2024 · HD

Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model

$497,187
Patricia Leal Dahia · University Of Texas Hlth Science Center · R01 · FY2025 · CA

Elucidating the Role of Tryptophan Hydroxylase 1 in Neuroendocrine Prostate Cancer

$497,109
Boyang Wu · Washington State University · R01 · FY2024 · CA